Flovent - glucocorticosteroid for inhalation and intranasal administration. As result of anti-inflammatory Flovent's effect the severity and frequency of asthma attacks are decreased, lung function is improved and the symptoms of COPD are reduced.
Indications for use:
Basic anti-inflammatory asthma treatment; adults - BA with mild, moderate and severe disease progress, children - effectiveness' lack of preventive therapy, carried out by other means; COPD; seasonal allergic rhinitis' prevention and treatment.
Dosage and administration:
As a basic therapy is used for a long time, even in the asthma attacks' absence. Therapeutic effect is usually developing within 4-7 days, although for some patients who hadn't previously received inhaled glucocorticosteroids, the effect can be observed as early as 24 hours after the start of treatment. Adults and children over 16 years usually appoints from 100 to 1000 mg two times/day; initial dose is determined according to the disease severity: mild course of asthma - by 100-250 mg 2 times/day; moderate - 250-500 mg 2 times/day; heavy - at 500-1000 mg 2 times/day. Children under the age of 4 years appoints remedy according to the disease severity, usually in a dose of 50-100 mg two times/day. Dosage change for elderly patients or patients with liver (kidney) disease is not required.